These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells. Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197 [TBL] [Abstract][Full Text] [Related]
5. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling. Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953 [TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells. Mikami Y; Asano M; Honda MJ; Takagi M J Cell Physiol; 2010 Apr; 223(1):123-33. PubMed ID: 20039267 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of cAMP-dependent protein kinase inhibitor gamma is required for BMP-2-induced osteoblastic differentiation. Zhao L; Yang S; Zhou GQ; Yang J; Ji D; Sabatakos G; Zhu T Int J Biochem Cell Biol; 2006; 38(12):2064-73. PubMed ID: 16870489 [TBL] [Abstract][Full Text] [Related]
8. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells. Singhatanadgit W; Salih V; Olsen I Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965 [TBL] [Abstract][Full Text] [Related]
9. cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms. Ghayor C; Ehrbar M; San Miguel B; Grätz KW; Weber FE Biochem Biophys Res Commun; 2009 Apr; 381(2):247-52. PubMed ID: 19217886 [TBL] [Abstract][Full Text] [Related]
10. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987 [TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshio K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC J Bone Miner Res; 2002 Aug; 17(8):1430-40. PubMed ID: 12162497 [TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655 [TBL] [Abstract][Full Text] [Related]
13. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730 [TBL] [Abstract][Full Text] [Related]
14. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Tang CH; Yang RS; Chien MY; Chen CC; Fu WM Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360 [TBL] [Abstract][Full Text] [Related]
16. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
17. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation. Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770 [TBL] [Abstract][Full Text] [Related]
18. Involvement of phosphodiesterase isozymes in osteoblastic differentiation. Wakabayashi S; Tsutsumimoto T; Kawasaki S; Kinoshita T; Horiuchi H; Takaoka K J Bone Miner Res; 2002 Feb; 17(2):249-56. PubMed ID: 11811555 [TBL] [Abstract][Full Text] [Related]